Study of effects on the retina morphological changes and vision of Aflibercept intravitreal injection in patients with macular edema due to central retinal vein occlusion.
Phase of Trial: Phase III
Latest Information Update: 18 Mar 2019
Price : $35 *
At a glance
- Drugs Aflibercept (Primary)
- Indications Central retinal vein occlusion; Retinal oedema
- Focus Therapeutic Use
- 15 Mar 2019 Status changed from recruiting to completed.
- 11 Jul 2014 New trial record